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Objective: This study was conducted to explore the association between sexual orientations and poly-
cystic ovary syndrome (PCOS)-related parameters.
Materials and methods: A cross-sectional study with participants recruited from the regular outpatient
clinic at the Department of Obstetrics and Gynecology at Taipei Medical University Hospital, Taipei,
Taiwan between July 2012 and December 2013 was carried out. A total of 97 women met the criterion of
having been diagnosed with PCOS. Among these 97 women, 89 were heterosexuals and eight were self-
identiﬁed as lesbians. At the same time, 78 women without PCOS were enrolled to serve as the control
group. Participants were given a standard questionnaire and had blood withdrawn for biochemical
analysis of androgen parametersdincluding total testosterone, androstenedione, sex hormone binding
globulin, free androgen index, 17b-estradiol (E2), luteinizing hormone, and follicular-stimulating hor-
mone. The biochemical data were measured to compare the PCOS clinical parameters present in people
of different sexual orientations (lesbians and heterosexuals).
Results: The women with PCOS, regardless of sexual orientation, had higher percentages and serum
levels of hyperandrogenism-related clinical parameters than the women without PCOS [acne (87.5% and
60.7% vs. 23.1%), p < 0.001]; hirsutism (62.5% and 57.3% vs. 15.4%, p  0.001)]; and biochemical pa-
rameters (total T, p < 0.05 or p < 0.001, and luteinizing hormone/follicular-stimulating hormone ratio,
p  0.001]. The sexual orientation of women with PCOS affected their body mass index (BMI), because
lesbians with PCOS possessed higher BMI than heterosexual women with PCOS (26.5 ± 1.9 vs.
22.5 ± 0.55; p < 0.05). However, hyperandrogenism-related clinical and biochemical parameters were
not signiﬁcantly different statistically between women with PCOS but of different sexual orientations.
Conclusion: Our preliminary data showed that sexual orientation inﬂuenced the BMI of women with
PCOS, but did not affect hyperandrogenism-related clinical or biochemical characteristics. This obser-
vation requires further conﬁrmation.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.y and Molecular Cell Biology,
uxing Street, Taipei, Taiwan.
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bstetrics & Gynecology. PublishedIntroduction
Polycystic ovary syndrome (PCOS) is a common endocrine dis-
order that causes substantial psychological, social, and economic
burden for women of various ages [1e5]. The prevalence of PCOS in
childbearing aged women is approximately 5e20% [6e8], andby Elsevier Taiwan LLC. All rights reserved.
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2003 criteria for the diagnosis of PCOS, the clinical expressions of
this disease include chronic anovulation, clinical or biochemical
signs of hyperandrogenism, and polycystic ovaries [11], which
contribute to the following clinical symptoms: irregular or absent
menstrual periods, infertility, excessive growth of body and facial
hair, adult acne, high blood pressure, and elevated cholesterol
levels. These clinical expressions are thought to result from the
imbalance of hormones and insulin resistance of the body.
Approximately 50e70% of women with PCOS were found to have
symptoms of insulin resistance [12], which contributes to the
clinical expression of prediabetes in women with PCOS [13].
Currently, PCOS is considered a genetic disease associated with
various conditions including infertility, type 2 diabetes, cardiovas-
cular disease, and ovarian cancer [14]. However, the exact patho-
physiology of this complex disease is still unclear.
As discussed above, PCOS is associated with psychological, so-
cial, and metabolic problems, as well as issues regarding infertility.
However, the relationship between sexual function and PCOS is
rarely discussed. Recently, only a few studies have indicated that
PCOS is also associated with particular sexual responses and sexual
dysfunction [15e17]. Based on the homosexual cases studies, Fer-
raresi and his colleagues [15] showed that women with PCOS had
higher levels of serum androgen and a lower sexual function index,
but no signiﬁcant association was found between body mass index
(BMI), serum androgen level, and sexual function. Another study
conducted by Stovall et al [17] demonstrated that an elevated BMI
was associated with a reduction in the orgasm/completion phase
during the sexual response cycle, but not associated with acne or
hirsutism. Mansson et al [16] further suggested that high BMI had
only a minor effect on sexual function, and the total serum
testosterone (T) level was positively associated with sexual satis-
faction. These homosexual cases studies results imply that BMI and
serum androgen levels might be independent factors that
contribute to the clinical expression of PCOS. As to the impact of
these PCOS-related physiological factors on sexual orientation, a
pilot study [18] also suggested that the prevalence of PCOS and its
related symptoms might not differ between lesbians and hetero-
sexual women. However, studies on different sexual orientations
are still under debate, and physiological factors may still vary be-
tween the two groups. For example, it was considered that lesbians
have higher T levels than heterosexual women [19]. However, the
evidence is still under debate, and very few studies have been done
on the relationship between sexual orientation and PCOS. More-
over, the majority of the previous studies were conducted on
Caucasians, so the association of PCOS with race, sexual orientation,
and hormonal factors is still poorly understood [20].
Thus, in the current study, we took advantage of being based in
Asia, because sexual dysfunction is an embarrassing issue and
seldom discussed in Asia [21]. We aimed to evaluate the association
between sexual orientation and PCOS-related physiological pa-
rameters, and to clarify the hormonal factors that may differ be-
tween different groups among Taiwanese people. Through the
quantitative analysis of questionnaires, patient history, and hor-
mone assays, we evaluated the physical activity, medical history,
ultrasound data, and various hormone levels of the patients
including 17b-estradiol (E2), luteinizing hormone (LH), follicular-
stimulating hormone (FSH), prolactin, total T, androstenedione
(A4), and sex hormone binding globulin (SHBG). The conventional
therapeutic targets of PCOS were aimed at the exhibited symptoms
relating to insulin resistance, such as overweight issues and hir-
sutism. The outcomes of this study advanced our understanding of
the relationship between PCOS and sexual orientation in Taiwanese
women and provided additional information about the features of
PCOS in people of different ethnic backgrounds. The study may alsocontribute to the improvement of future care for womenwith PCOS
from various cultural backgrounds.
Methods
The studywas carried out by using a cross section of participants
recruited from the regular outpatient clinic at the Department of
Obstetrics and Gynecology at Taipei Medical University Hospital,
Taipei, Taiwan between July 2012 and December 2013.
Amedical history questionnairewas used to recruit participants.
Participants had to meet the following criteria: (1) be between the
ages of 20 years and 35 years (this was done to avoid including
those who were experiencing the hormonal effects of puberty and
premature menopause), (2) have at least one functional ovary, (3)
not taking oral contraceptives at the time when blood was drawn,
(4) display no menopausal symptoms (deﬁned by no period in the
past 12 months accompanied by hot ﬂashes, vaginal dryness, and
dizziness) at the time of participation, and (5) report to have never
been diagnosed with Cushing's syndrome, androgen-secreting tu-
mors, or congenital adrenal hyperplasia on the medical history
questionnaire that was used for this study. Of the 97 women who
met the criteria and were diagnosed with of PCOS, 89 were het-
erosexuals and eight were lesbians. At the same time, 75 women
without PCOS were recruited to serve as the non-PCOS control
group. An unpaired t test and two-sided p value were used.
Data collection and laboratory analysis
Upon meeting the eligibility criteria, participants were sched-
uled to visit our university-afﬁliated hospital. During the ﬁrst clinic
visit, participants consented to participate in the study and
completed the questionnaires. They were then interviewed
regarding their physical activity and medical history. At the second
visit, participants underwent a transvaginal or transabdominal ul-
trasound, and a fasting venipuncture of hormone assays, including,
E2, FSH, LH, prolactin, total T, A4, and SHBG. The entire hormone
assay was done at a laboratory at Taipei Medical University Hospital
using the electrochemiluminescence immune assay. All study in-
struments and protocols were approved by the University Institu-
tional Review Board (TMU 201202017). The participants completed
a lengthy questionnaire about their sexual life history to determine
their sexual orientation.
Measurement and observation
Demographic information (race, age, sexual orientation, and
education) was obtained from the screening/recruitment forms and
questionnaires. Sexual orientation was based primarily on self-
identiﬁcation with conﬁrmatory questions regarding sexual
behavior, attraction, and sexual history over the past 2 years.
PCOS diagnoses were made by a reproductive endocrinologist,
who was blind to the sexual orientation of each participant, using a
modiﬁed version of the 2004 and 2009 Rotterdam diagnostic
criteria for PCOS [8,11]. In brief, a case of PCOS was identiﬁed when
at least two of the following three criteria were met: (1)
biochemical and/or clinical hyperandrogenism, (2) oligomenor-
rhea, and (3) polycystic ovaries on ultrasound, after exclusion of
known disorders.
Clinical hyperandrogenismwas based on current adult acne and
excessive hair growth (hirsutism). Hirsutism was determined by
using the modiﬁed FerrimaneGallway scale in which women
marked seven body areas (0e4) according to their hair density; a
score of 8 or higher indicates excessive hair growth. Biochemical
hyperandrogenismwas deﬁned by elevated total T and A4 (>2.4 ng/
mL) concentrations [22]. Oligomenorrheawas deﬁned as menstrual
Figure 1. Comparison of body mass index (BMI) in heterosexuals, lesbians, and non-
polycystic ovary syndrome (non-PCOS) groups. BMI in the PCOS lesbian group was
signiﬁcantly higher than that in the PCOS heterosexual and non-PCOS groups.
*p < 0.05.
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cycles per year (at the time that blood was drawn), and was veriﬁed
by a reproductive endocrinologist who reviewed participants' ﬁles.
BMI was used to create the following categories: <25 (under-
weight/normal); 25.0e29.0 (overweight), and 30.0 (obesity). In
addition, blood assays were conducted to obtain related hormone
assays. Overall, the PCOS diagnosis was conﬁrmed via a thorough
review of participant ﬁles and blood results as well as ultrasound.
Results
Clinical characteristics of PCOS in those with different sexual
orientations and controls
The clinical and biochemical features of PCOS are shown in
Table 1. The PCOS group was subdivided into two groups based on
different sexual orientations (heterosexuals and lesbians), and
compared with the non-PCOS group (control groups). In terms of
age, women in the control groups were older than those in both of
the PCOS groups. As expected, acne and hirsutismdclinical char-
acteristics of hyperandrogenismdoccurred more frequently in the
PCOS groups. The group that comprised lesbians had a higher BMI
than the group made up of heterosexuals (p¼ 0.04) and the control
group (p¼ 0.04). The BMI of the heterosexuals was similar to that of
the non-PCOS group (p ¼ 0.92; Fig. 1).
PCOS patients are associated with higher serum levels of
testosterone
Consistent with the above ﬁndings regarding clinical hyper-
androgenism, both the lesbian and heterosexual groups with PCOS
displayed signiﬁcant increase in the levels of total T (0.34 ± 0.13 ng/
mL and 0.41 ± 0.24 ng/mL vs. 0.25 ± 0.12 ng/mL, respectively, both
p < 0.05) and an abnormally higher ratio of LH and FSH (2.20 ± 0.65
and 2.90 ± 1.80 vs. 0.88 ± 0.34, respectively, both p < 0.05). How-
ever, there was no difference in terms of total T and A4 between
heterosexuals and lesbians in the PCOS group (Fig. 2A and B). The
level of SHBG, a surrogate marker of insulin resistance, seemed to
be reduced in lesbians of the PCOS group, contributing to the higher
levels of free androgen index, which was calculated using the for-
mula: Testosterone/SHBG  100, compared with those in the het-
erosexuals of the PCOS group; however, both did not reach
statistical signiﬁcance (Fig. 3A and B).Table 1
The clinical and biochemical baseline characteristics of PCOS in women of different sexu
PCOS
L (n ¼ 8) H (n ¼ 89)
Age (y) 25.0 ± 5.1 26.5 ± 5.6
BMI (kg/m2) 26.5 ± 6.5 22.5 ± 5.2
Acne 87.5 60.7
Hirsutism 62.5 57.3
Oligomenorrhea 50.0 59.6
E2 (pmol/L) 59.1 ± 13.4 129.7 ± 151.2
LH (IU/L) 12.7 ± 5.1 15.1 ± 8.1
FSH (IU/L) 5.7 ± 1.3 5.6 ± 2.1
LH/FSH ratio 2.20 ± 0.65 2.90 ± 1.80
Prolactin (ng/mL) 21.2 ± 13.3 13.3 ± 6.3
T (ng/mL) 0.34 ± 0.13 0.41 ± 0.24
A4 (ng/mL) 2.4 ± 1.0 2.4 ± 1.5
SHBG (nmol/L) 38.6 ± 29.3 59.3 ± 36.7
FAI 0.08 ± 0.04 0.07 ± 0.11
Data are presented as % or mean ± SD. The p values were derived from unpaired Studen
A4¼ androstenedione; BMI¼ bodymass index; C¼ non-PCOS controls; E2¼ 17b-estradi
with PCOS; L ¼ Lesbian with PCOS; LH ¼ luteinizing hormone; N.A. ¼ not applicable; PC
testosterone.Taken together, the sexual orientation of PCOS patients might be
different between high and normal BMI groups; however,
androgen-related clinical or biochemical characteristics might not
be strongly associated with sex orientation in these PCOS patients.Discussion
One of the important ﬁndings of the current study is that a high
rate of lesbians (9%) was found among the PCOS patients, demon-
strated by the fact that PCOS patients were recruited from the
regular gynecology and obstetrics clinic rather than the infertility
clinic. This is important given that the vast majority of PCOS studies
have been done on patients in infertility clinics [23e25]. No les-
bians would have attended fertility clinics in Taiwan as it is not
approved by law. Thus, we evaluated the clinical and biochemical
indications of the PCOS patients in the regular clinics, and found
that an important parameter of PCOS, BMI, was greater in the
lesbian group and had a positive association with PCOS.
This observation suggested that high BMI in lesbians could be a
risk factor that subsequently causes severe insulin resistance.
Complications regarding a metabolic disorder could be a challenge
for PCOS progression. This is a reasonable conclusion because les-
bians are reported to be at high risk of obesity and cardiovascular
disease [25]. It was then not a surprising result that reduced SHBG
in the lesbian group was observed, although it did not reachal orientations.
Controls L vs. H L vs. C H vs. C
C (n ¼ 78) p p p
30.7 ± 6.5 0.469 0.019 <0.001
22.4 ± 5.0 0.042 0.043 0.922
23.1 0.132 <0.001 <0.001
15.4 0.542 0.001 <0.001
30.8 0.433 0.234 <0.001
79.8 ± 69.0 <0.001 0.027 0.006
5.2 ± 2.4 0.422 0.004 <0.001
6.4 ± 2.6 0.874 0.475 0.034
0.88 ± 0.34 0.242 0.001 <0.001
15.6 ± 6.8 0.141 0.049 0.027
0.25 ± 0.12 0.432 0.047 <0.001
N.A. 0.936
N.A. 0.125
N.A. 0.790
t t test.
ol; FAI¼ free androgen index; FSH¼ follicle-stimulating hormone; H¼ heterosexual
OS ¼ polycystic ovary syndrome; SHBG ¼ sex hormone binding globulin; T ¼ total
Figure 2. Serum concentrations of total testosterone (ng/mL) and androstenedione
(ng/mL) in women with polycystic ovary syndrome (PCOS) of different sexual orien-
tations (heterosexuals and lesbians), compared with women with non-PCOS. (A) PCOS
patients had higher levels of total testosterone in both the heterosexual and lesbian
groups than non-PCOS patients, where there was no signiﬁcant difference between
heterosexuals and lesbians. (B) There were no considerable differences in andro-
stenedione between the heterosexual and lesbian groups. ***p < 0.0001.
Figure 3. Serum concentrations of sex hormone binding globulin (SHBG) and free
androgen index (FAI) in women with polycystic ovary syndrome (PCOS) of different
sexual orientations (heterosexuals and lesbians). (A) The trend of lower levels of SHBG
was observed in the lesbian group. (B) FAI increased in the lesbian group; however,
they were not statistically signiﬁcantly different.
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of insulin resistance. This hypothesis, however, requires further
investigation. Most notably, we did not observe statistically
increased levels of androgen-related hormones, such as total T and
A4, in lesbians with PCOS, when compared with heterosexual
women with PCOS. In fact, although PCOS patients had statistically
higher total T serum levels than controls did, our data showed that
total T in young Taiwanese womenwas not as high as in advanced-
aged women as reported previously [26e28]. This is logical in view
of the fact that natural total T levels rise with age in women [26].
This, however, could be noted as the age effect in PCOS patients.
Furthermore, data on advanced-aged women are usually obtained
from infertility clinics where patients often have received various
hormonal treatments from fertility treatments they have sought in
the past. Although the sample size was relatively small, the data
presented in this manuscript provide a preliminary observation of
the association between sexual orientation and PCOS in Taiwan.
Herein, we have concluded that a high level of BMI in lesbians may
be a risk factor for severe insulin resistance and consequently cause
a metabolic disorder or symptoms such as Diabetes Mellitus (DM)
or PCOS. Sexual orientation might not inﬂuence the level of
androgen-related clinical or biochemical characteristics of women
with PCOS in Taiwan.
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